Ask AI
ProCE Banner Activity

A Monumental Moment: Advances Toward HBV Functional Cure From EASL 2026

Clinical Thought

Data from EASL show that this is an exciting time for the field of HBV. Here’s why I think we have made a big advance toward making functional cure an achievable goal of HBV therapy.

Released: June 11, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This educational activity is supported by an independent medical education grant from GSK.

GSK

Target Audience

This activity is intended for US physicians, including gastroenterologists and hepatologists, nurse practitioners, physician associates, and other healthcare professionals involved in the care of people living with chronic hepatitis B.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply current guidelines to increase timely diagnosis and treatment of HBV

  • Describe the potential role of investigational therapies designed to achieve functional cure in HBV

  • Effectively counsel patients on the benefits of functional cure

Financial Disclosures

Primary Author

Jordan J. Feld, MD, MPH: consultant/advisor/speaker: AbbVie, Aligos, Arbutus, AstraZeneca, AusperBio, Gilead, Vir; researcher: Gilead, GSK, Vir.